OVAGEN - THE COMPANY

The Ovagen team has a wealth of experience. Our Research and Development team have 100 years of combined life-sciences related R&D experience. Our founder's previous venture was sold in 2002 to Charles River Laboratories Inc and our Operational team has a combined 75 years of life-science related experience.

• Ovagen is a biotechnology company that has developed a process of producing germ free (GF) chicken eggs and GF birds in commercial quantities for use primarily in the pharmaceutical industry.

• Ovagen has received patent protection in both Europe and the US for the process by which it produces GF eggs and further patent approvals are pending.

• The Company has achieved proof of concept (GF chickens have been bred through 3 generations) and funds have been raised for the construction of a production facility which will be used to produce the initial flocks of GF birds (for subsequent expansion into new large-scale GF facilities) and GF eggs, initially for customer validation.

• To produce GF eggs on a large-scale, Ovagen will use sterile manufacturing technologies as developed in the pharmaceutical industry in conjunction with biosafety decontamination techniques and best-practice poultry husbandry methods.

• GF eggs will be available from 4Q 2009.

• The Company intends creating a facility that will have the capacity to produce ca. 3 million eggs per annum by 2012.

THE FOUNDERS OF OVAGEN

Leonard Moran (Dip. Ag. Sci., F.I.Biol., F.I.A.T., A.I.S.T.).
Chief Executive Officer
Leonard has led the business since inception and was the primary driver of the development of the Ovagen process to produce GF eggs. Prior to establishing Ovagen, Leonard founded Biological Laboratories Europe Limited (Biolabs). This was a clinical research business that was established in Ireland in 1976 and sold to Charles River Laboratories in 2002 for €28m. Leonard has amassed a wide range of GF technology skills and these have enabled him with the others in the management team to perfect the Ovagen process. Prior to founding Biolabs, Leonard spent 8 years with the British Medical Research Council (MRC) from 1968-76 where he focused on clinical research and specifically breeding SPF animals. In addition he has a wealth of practical operational and construction experience associated with biological facilities.

Tim Rowan (B.V.Sc., Ph.D., M.R.C.V.S., C.Biol., M.I.Biol.).
Chief Technical Officer
At Ovagen, Tim is responsible for leading the technical and scientific development of the business. He has worked closely with Leonard Moran to develop the technology necessary to produce GF eggs in sustainable commercial volumes. Tim retired from Pfizer Limited in 2007, where he had spent 15 years, most recently as Senior Director of Pfizer's Global Alliances Animal Health group. While at Pfizer, he had a number of increasingly senior roles, both managerial and technical. He had pivotal roles in the successful launch of 6 major animal health products and took them from discovery through product development and registration to successful market launches, each with sales in excess of $100 million p.a. Prior to Pfizer, Tim held senior positions at the Veterinary Faculty in the University of Liverpool (1979 - 1991) and with the Agricultural Research Council (1978 - 1979). He has more than 80 scientific publications

NEW BUILDING

August 2008 (2500msq)
First generation germ-free flocks,
Isolators, Incubators
Laboratories
Egg processing
R&D
Head Office.

Lower Floor Provides:

• SPF flocks
• Isolators for egg removal
• Large Germ-Free (GF) Isolators
• GF suite for flock of 550 birds
• GF 'space' suits & decontamination showers
• GF feed handling
• GF egg collection & packaging

Upper Floor Provides:

• SPF showers
• Incubating/Hatching Isolators
• Transport Isolators
• Laboratories
• Head Offices